Finally, we performed rescue experiments to determine whether ROCK2-mediated inhibition of ferroptosis leads to Pemigatinib resistance in CCA cells, which is dependent on the UBA52–Drp1 axis. The gene discussed is UBA52; the disease is cholangiocarcinoma.